Sector ratings Laboratorios Farmaceuticos Rovi, S.A.

Stocks

Market Closed - BME Other stock markets 11:35:29 2026-08-07 am EDT			5-day change	1st Jan Change
58.35 ^EUR	-0.43%		-0.34%	-8.11%

Jul. 23	Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026
Jul. 23	Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
LABORATORIOS FARMACEUTICOS ROVI, S.A.	3.45B		BBB
ELI LILLY AND COMPANY	1,057B		A
JOHNSON & JOHNSON	625B	-	BBB	-	-
ABBVIE INC.	435B		AA	-
ROCHE HOLDING AG	363B		AA
NOVARTIS AG	296B		AAA
ASTRAZENECA PLC	249B		A
AMGEN INC.	222B		A
NOVO NORDISK A/S	209B		A
GILEAD SCIENCES, INC.	165B		AA
PFIZER INC.	153B		A
BRISTOL-MYERS SQUIBB COMPANY	132B		A
VERTEX PHARMACEUTICALS INCORPORATED	126B		AA
GSK PLC	106B		AA
SANOFI	104B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	71.54B		AA
BAYER AG	56.57B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	56.09B		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	53.41B		AA
HALEON PLC	43.91B		AA
Average	226.33B		AA
Weighted average by Cap.			AA